Codian
Codian is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Codian.
Codian is a company.
Key people at Codian.
Key people at Codian.
Cadian Capital Management (often referred to as Cadian) is a New York-based global long/short equity hedge fund manager with approximately $1.79 billion in assets under management as of June 30, 2025.[1][3] Its mission centers on fundamental research-driven stock selection with a value-oriented, long-term approach, maintaining a conservative net beta exposure while investing across technology, media, telecommunications, healthcare, industrials, retail, consumer, and related sectors.[1] The firm emphasizes deep industry focus to identify long and short opportunities, influencing the startup and public market ecosystem through concentrated holdings in high-growth tech names like Global-E Online (10.36% of portfolio), Guardant Health (9.27%), and Procore Technologies (6.53%).[3] Recent activity shows a 41% turnover rate, with new buys in fintech and health tech like Confluent and Flywire, reflecting adaptive momentum amid market shifts.[3]
Cadian Capital Management was established in 2007 by Eric Bannasch in New York.[7] Bannasch, with a background in equity investing, founded the firm to pursue a disciplined, research-intensive strategy at the intersection of technology and value investing.[1][7] Key partners have evolved the focus from broad equities to a sharpened emphasis on long/short positions in tech-heavy sectors, navigating market cycles with a conservative beta profile.[1] Early traction built on fundamental analysis, growing to manage assets for 9 clients while maintaining a low-profile evolution amid hedge fund consolidation.[3]
Cadian rides the wave of tech-value convergence, capitalizing on undervalued growth stocks in e-commerce (Global-E), health tech (Guardant Health, Evolent), and SaaS (Procore) amid AI-driven market rotations.[1][3] Timing aligns with 2025's post-hype correction, where long/short strategies thrive on dispersion between winners like fintech enablers and overvalued shorts.[3] Favorable forces include regulatory scrutiny on big tech and rising demand for precision healthcare, boosting portfolio tilts; the firm shapes the ecosystem by amplifying liquidity and validation for mid-cap innovators through significant stakes.[3]
Cadian is poised to benefit from sustained tech dispersion, potentially expanding AUM via outperformance in AI-adjacent health and fintech as turnover moderates.[3] Trends like non-U.S. equity tilts and leverage in portfolios could enhance its edge, evolving influence toward more activist-like impact on startup IPOs.[3] This value-tech fusion positions Cadian as a steady force, echoing its foundational bet on undervalued innovation.
